BSECompany Update30 Sept 2026 · 30 Sept 2026, 06:29 pm
Pursuant to Regulation 30 read with Part A of Schedule III of SEBI (LODR) Regulations, 2015, we would like to inform you that the Company has received approval of its members by Special Resolution passed in the 41st AGM of the Company held on September 30, 2026 for appointment of Mr. Dipankar Dasgupta as Independent Non-Executive Director of the Company with effect from October 01, 2026 in place of retiring Independent Non Executive Director Mr. ....
Gennex Laboratories Ltd · 531739
✦ AI SummaryMgmt Change
Gennex Laboratories Ltd has announced the appointment of Mr. Dipankar Dasgupta as an Independent Non-Executive Director, replacing Mr. Amudala Sreeramulu Nageswar Rao, with effect from October 1, 2026.
Analysis Scores
Earnings Impact2/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Gennex Laboratories Ltd - 531739 - Announcement under Regulation 30 (LODR)-Change in Management
Attachments (1)
📄pdf
Download →
2768e790-3d52-451f-963a-3beefb45258a.pdf
View document text
CG GENNEX
LABORATORIES LIMITED
Ref: GLL/BSE/2026-27/Sep- ————y—ou can ty te: September 30, 2026
To To
The General Manager, The Listing Manager,
Corporate Relations Department, The Ahmedabad Stock Exchange Limited
BSE Limited A-2, Kamdhenu Complex, Opp. Sahajanand
Phiroze Jeejecbhoy Towers, College, 120 Feet Ring Road, Panjara Pol,
Dalal Street, Mumbai — 400001. Ambawadi, Ahmedabad - 380015.
Maharashtra State, India. Gujarat State, India.
Script Code: 531739 Script Code:
The Calcutta Stock Exchange Limited,
#7, Lyons Range, Murgighata,
Dalhousie, Kolkata - 700001,
West Bengal State, India.
Scrip Code: 26178
Sub: Appointment and Retirement of Independent (Non-Executive) Directors of the
Company
Ref: Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015
Dear Sir/Madam,
Pursuant to Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations
and Disclosure Requirements), Regulations, 2015 ("Listing Regulations"), we would like to
inform you that the Company has received approval of its members by Special Resolution
passed in the 41* Annual General Meeting of the Company held on September 30, 2026 for
appointment of Mr. DIPANKAR DASGUPTA (DIN: 05312364) as Independent (Non-
Executive) Director of the Company with effect from October 01, 2026 in place of retiring
Independent (Non-Executive) Director, Mr. AMUDALA SREERAMULU NAGESWAR RAO
(DIN: 07030259) whose current period of office has expired on the date of AGM i.e. September
30, 2026.
Mr. DIPANKAR DASGUPTA will be a Non-Executive & Independent Director and he is not
related to the Promoter or Promoter Group and fulfils the criteria as required under the
provisions of the Companies Act, 2013 and the Rules framed thereunder and the Listing
Regulations.
The relevant details of the captioned appointment and retirement, as per the requirements of
Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015,
read with SEBI Circular #SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, are
given in the enclosed Annexure A along with disclosure in Form B under the SEBI (Prohibition
of Insider Trading) Regulations, 2015.
We request you to take note of the above information on record and acknowledge the receipt
of the same.
Thanking you,
Yours faithfully,
For Gennex Laboratories Limited Bra
aD) raat
Dine Kutna? Kpiriya \O\
Company Secretary & Compliance Officer
Gennex Laboratories Limited
Akash Ganga, 4th Floor, Plot No.144, Srinagar Colony, Hyderabad-500073, Telangana Stale, India | Tel : +91-40-67334400 (30 Lines), 23746451
Factory : Sy.No.133, Bollaram Village, Jinnaram Mandal, Sangareddy Dist - 502 325, Telangana State, India. Tel : +91-08458 295516,
info@gennexlab.com, www.gennexlab.com | CIN : L24230TG1990PLC011168
YEE €
GcNNex
LABORATORIES LIMITED
——-———YsEU con rust
Annexure A
Disclosures as per the Listing Regulations and SEBI Circular no. SEBI/HO/CFD/CFD-
PoD-1/P/CIR/2023/123 dated July 13, 2023:
A. APPOINTMENT OF INDEPENDENT DIRECTORS:
Particulars Details
Mr. DIPANKAR DASGUPTA __
Name of the Director
Reasons for Change Appointment
| Date of Appointment October 01, 2026
Term of Appointment Independent (Non-Executive) Director
B.Com.; CA (Inter)
Mr. Dasgupta has more than 35 years of
experience in the finance, economy and
Brief Profile
management, the proficient English speaker on
the current economic and financial affairs and
having extensive command on the various foreign
_languages including English. _
Relationship Inter-se Directors / Key
Not related to any Directors/ Key Managerial
Managerial Personnel
Personnel of the Company.
Information as required under Circular
Mr. DIPANKAR DASGUPTA is not debarred from
No. NSE/CML/2018102 dated June
holding office of a director by virtue of any SEBI
20, 2018 issued by NSE
_ order or any other such authority
B. RETIREMENTS OF INDEPENDENT DIRECTORS:
# Particulars Description
1. | Name of the Director Mr. Amudala Sreeramulu Nageswar Rao
| Mr. Amudala Sreeramulu Nageswar Rao (DIN: |
9 Reason for Change: 07030259) ceases to be an Independent |
| (Retirement) Director of the Company upon completion of
his first term as an Independent Director.
Date of .
| 3. A . /Cessation SS e» pteY mbearr G3 0, 2 2022 6 -
4. | Term Of Appointment N.A.
5. Brief Profile (in case of NA.
appointment)
Disclosure of relationship
6. | between Directors (in case of | N.A.
appointment of a Director)
For ve Limited
Dinesh Kumanr ae
Company Secretary & Compliance Officer
Membership No. A/ 19293
Gennex Laboratories Limited
Akash Ganga, 4th Floor, Plot No.144, Srinagar Colony, Hyderabad-500073, Telangana State, India | Tel : +91-40-67334400 (30 Liries), 23746451
Factory : Sy,No.133, Bollaram Village, Jinnaram Mandal, Sangareddy Dist - 502 325, Telangana State, India. Tel : +91-08458 295516,
info@gennexlab.com, www.gennexlab.com 4 GIN ; L24230TG1990PLC011168
FORM B
SEBI (Prohibition of Insider Trading) Regulations, 2015
[Regulation 7 (1) (b) read with Regulation 6(2) — Disclosure on becoming a Key Managerial
Personnel/Director/Promoter/Member of the promoter group]
Name of the Company: Gennex Laboratories Limited
ISIN of the Company: INESO9C0 1026
Details of Securities held on appointment of Key Managerial Personnel (KMP) or Director or upon becoming a
Promoter or member of the promoter group of a listed company and immediate relatives of such persons and
by other such persons as mentioned in Regulation 6(2).
Name, PAN, CIN/ DIN& Category of Date of Securities held at the time of % of
Address with contact nos. Person (KMP | appointment appointment of KMP/ Director or Shareho
/Director or of KMP/ upon becoming Promoter or lding
Promoter or Director/OR member of the promoter group
member of Date of Type of securities (For e.g.- No
the promoter | becoming Shares, Warrants,
group/Imme | Promoter/me | Convertible Debentures,
diate relative | mber of the Right entitlements, etc.)
to/others, promoter
etc) group
1 2 3 4 5 6
Name: Dipankar Dasgupta | Director 01.10.2026 NIL NIL | NIL
PAN: BEKPD9415D
DIN: 05312364
Address:
289A, Banerjee Para Road,
Chatterjee Bagan, West
Putiary, Kolkata - 700041.
Email:dgdipankarca@yahoo
Contact No.: +91-
8697919168
Note: “Securities” shall have the meaning as defined under regulation 2(1)() of SEBI (Prohibition of Insider
Trading) Regulations, 2015.
Details of Open Interest (OJ) in derivatives on the securities of the company held on appointment of KMP or
Director or upon becoming a Promoter or member of the promoter group of a listed company and immediate
relatives of such persons and by other such persons as mentioned in Regulation 6(2).
Open Interest of the Future contracts held at the time Open Interest of the Option Contracts held at the time
of appointment of Director/KMP or upon becoming of appointment of Director/KMP or upon becoming
Promoter/member of the promoter group Promoter/member of the promoter group
Contract Number of | Notional value | Contract Number of | Notional value
specifications units (contracts | in Rupee terms | specifications units (contracts | in Rupee terms
lot size) * lot size)
7 8 9 10 11 12
Note: In case of Options, notional value shall be calculated based on premium plus strike price of options.
Dipankar Das
Digitally signed by Dipankar Das
Gupta Gupta
Date: 2026.09.30 13:57:35 +05'30'
Name & Signature: Dipankar Dasgupta
DIN #: 05312364
Date: September 30, 2026
Place: Kolkata